DBV Technologies (DBVT) Free Cash Flow Growth (3y) (2017 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 24.91% |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 20.11% |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 14.71% |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -10.65% |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 31.42% |
| 10 | DBV Technologies | 8.00 Bn | 7.77 Bn | -3.90 Mn | -33.19% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -33.19% |
| Dec 31, 2025 | -14.15% |
| Sep 30, 2025 | -16.82% |
| Jun 30, 2025 | -47.88% |
| Mar 31, 2025 | -130.24% |
| Dec 31, 2024 | 14.93% |
| Sep 30, 2024 | 0.12% |
| Jun 30, 2024 | -5.92% |
| Mar 31, 2024 | 0.33% |
| Dec 31, 2023 | 25.19% |
| Sep 30, 2023 | 22.54% |
| Mar 31, 2023 | 25.42% |
| Dec 31, 2022 | -34.30% |
| Sep 30, 2022 | 44.03% |
| Jun 30, 2022 | 50.08% |
| Dec 31, 2021 | 49.23% |
| Sep 30, 2021 | 42.23% |
| Jun 30, 2021 | 26.92% |
| Dec 31, 2020 | 35.69% |
| Dec 31, 2019 | 44.50% |
| Dec 31, 2018 | -122.67% |
| Dec 31, 2017 | -112.78% |